- Home
- ASND vs IONQ Comparison
ASND vs IONQ Comparison
Compare ASND & IONQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- IONQ
- Stock Information
- Founded
- ASND 2006
- IONQ 2015
- Country
- ASND Denmark
- IONQ United States
- Employees
- ASND N/A
- IONQ N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- IONQ Wholesale Distributors
- Sector
- ASND Health Care
- IONQ Industrials
- Exchange
- ASND Nasdaq
- IONQ Nasdaq
- Market Cap
- ASND 9.1B
- IONQ 8.5B
- IPO Year
- ASND 2015
- IONQ N/A
- Fundamental
- Price
- ASND $158.14
- IONQ $26.79
- Analyst Decision
- ASND Strong Buy
- IONQ Strong Buy
- Analyst Count
- ASND 15
- IONQ 5
- Target Price
- ASND $202.00
- IONQ $40.80
- AVG Volume (30 Days)
- ASND 562.0K
- IONQ 18.9M
- Earning Date
- ASND 05-05-2025
- IONQ 05-07-2025
- Dividend Yield
- ASND N/A
- IONQ N/A
- EPS Growth
- ASND N/A
- IONQ N/A
- EPS
- ASND N/A
- IONQ N/A
- Revenue
- ASND $376,478,932.00
- IONQ $43,073,000.00
- Revenue This Year
- ASND $61.43
- IONQ $102.28
- Revenue Next Year
- ASND $73.07
- IONQ $99.79
- P/E Ratio
- ASND N/A
- IONQ N/A
- Revenue Growth
- ASND 36.34
- IONQ 95.41
- 52 Week Low
- ASND $111.09
- IONQ $6.22
- 52 Week High
- ASND $169.37
- IONQ $54.74
- Technical
- Relative Strength Index (RSI)
- ASND 55.10
- IONQ 54.89
- Support Level
- ASND $153.17
- IONQ $23.49
- Resistance Level
- ASND $165.42
- IONQ $25.87
- Average True Range (ATR)
- ASND 10.68
- IONQ 2.59
- MACD
- ASND 1.20
- IONQ 0.44
- Stochastic Oscillator
- ASND 82.40
- IONQ 84.53
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About IONQ IonQ Inc.
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems, and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.